home / stock / arwr / arwr quote
Last: | $28.79 |
---|---|
Change Percent: | 0.31% |
Open: | $28.75 |
Close: | $28.70 |
High: | $29.08 |
Low: | $28.04 |
Volume: | 247,500 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$28.79 | $28.75 | $28.7 | $29.08 | $28.04 | 247,500 | 03-28-2024 |
$28.7 | $28.21 | $28.7 | $28.87 | $27.85 | 537,604 | 03-27-2024 |
$27.84 | $28.21 | $27.84 | $28.45 | $27.5 | 710,015 | 03-26-2024 |
$27.89 | $27.31 | $27.89 | $27.95 | $27.31 | 517,415 | 03-25-2024 |
$27.21 | $28.16 | $27.21 | $28.36 | $27.18 | 712,149 | 03-22-2024 |
$28.23 | $28.97 | $28.23 | $29.93 | $28.12 | 1,103,884 | 03-21-2024 |
$28.16 | $27.5 | $28.16 | $28.38 | $27.07 | 926,648 | 03-20-2024 |
$27.77 | $28.06 | $27.77 | $28.38 | $27.54 | 1,002,171 | 03-19-2024 |
$28.14 | $28.28 | $28.14 | $28.36 | $27.21 | 1,273,850 | 03-18-2024 |
$28.28 | $27.16 | $28.28 | $29.01 | $27 | 3,736,099 | 03-15-2024 |
$27.42 | $28.16 | $27.42 | $28.3 | $27.01 | 1,621,736 | 03-14-2024 |
$28.59 | $28.51 | $28.59 | $29.15 | $28.19 | 1,484,865 | 03-13-2024 |
$28.55 | $29.23 | $28.55 | $29.43 | $28.26 | 1,423,347 | 03-12-2024 |
$29.4 | $33.01 | $29.4 | $33.02 | $29.26 | 2,298,447 | 03-11-2024 |
$33.45 | $33.58 | $33.45 | $35.47 | $33.38 | 1,019,490 | 03-08-2024 |
$33.2 | $35.63 | $33.2 | $35.8 | $33.135 | 1,105,190 | 03-07-2024 |
$35.4 | $34.8 | $35.4 | $35.66 | $34.12 | 1,627,863 | 03-06-2024 |
$34.08 | $34.73 | $34.08 | $35.72 | $33.74 | 867,376 | 03-05-2024 |
$35.11 | $36.6 | $35.11 | $36.72 | $34.73 | 1,237,227 | 03-04-2024 |
$36.08 | $32.36 | $36.08 | $36.24 | $32.2979 | 2,242,379 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Arrowhead Pharmaceuticals Inc. Company Name:
ARWR Stock Symbol:
NASDAQ Market:
- Expanded Access Program initiated to make investigational plozasiran available to patients with familial chylomicronemia syndrome - New SHASTA-2 Phase 2 clinical data in patients with severe hypertriglyceridemia to be presented at ACC.24 Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR...
2024-03-20 18:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
U.S. stocks were lower, with the Dow Jones index falling more than 150 points on Monday. Shares of EQT Corporation (NYSE: EQT) fell sharply during...